Diabetes Tech Society Gets FDA Buy-In For Glucose Monitor Surveillance Program
This article was originally published in The Pink Sheet Daily
Executive Summary
The proposed surveillance program would test marketed blood glucose monitor systems to ensure they are performing at the level expected when they were cleared. It was met with support from FDA, device companies, academics and patient advocates.